Gentamicin Sulfate Ophthalmic Solution USP
- Manufacturer
- Proficient Rx LP
- Effective date
- 2025-05-01
- Label type
- HUMAN PRESCRIPTION DRUG LABEL
- Version
- 3
- Source
- full-release
- Hydrated at
- 2026-05-31 21:33:04
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
Sterile
DESCRIPTION: Gentamicin Sulfate is a water-soluble antibiotic of the aminoglycoside group. Gentamicin Sulfate Ophthalmic Solution is a sterile, aqueous solution buffered to approximately pH 7 for ophthalmic use. Gentamicin is obtained from cultures of Micromonospora purpurea. It is a mixture of the sulfate salts of gentamicin C1, C2, and C1A. All three components appear to have similar antimicrobial activities. Gentamicin sulfate occurs as white powder and is soluble in water and insoluble in alcohol. The structure is as follows:

Established name: Gentamicin Sulfate
Chemical name: 0-3-Deoxy-4-C-methyl-3-(methylamino)-β-L-arabinopyranosyl-(1→6)-0-[2,6-diamino-2,3,4,6-tetradeoxy-α-D-erythro-hexopyranosyl-(1→4)]-2-deoxy-D-streptamine.
Ingredients: Each mL contains: Active: Gentamicin Sulfate USP (equivalent to 3 mg gentamicin). Preservative: Benzalkonium Chloride 0.1 mg (0.01%). Inactives: Sodium Chloride, Dried Sodium Phosphate, Tyloxapol, Sodium Hydroxide and/or Hydrochloric Acid (to adjust pH) and Purified Water.
CLINICAL PHARMACOLOGY SECTION
CLINICAL PHARMACOLOGY: Microbiology: Gentamicin sulfate is active in vitro against many strains of the following microorganisms:
Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pyogenes, Streptococcus pneumoniae, Enterobacter aerogenes, Escherichia coli, Haemophilus influenzae, Klebsiella pneumoniae, Neisseria gonorrhoeae, Pseudomonas aeruginosa, and Serratia marcescens.
INDICATIONS & USAGE SECTION
INDICATIONS AND USAGE: Gentamicin Sulfate Ophthalmic Solution is indicated in the topical treatment of ocular bacterial infections, including conjunctivitis, keratitis, keratoconjunctivitis, corneal ulcers, blepharitis, blepharoconjunctivitis, acute meibomianitis, and dacryocystitis caused by susceptible strains of the following microorganisms: Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pyogenes, Streptococcus pneumoniae, Enterobacter aerogenes, Escherichia coli, Haemophilus influenzae, Klebsiella pneumoniae, Neisseria gonorrhoeae, Pseudomonas aeruginosa, and Serratia marcescens.
CONTRAINDICATIONS SECTION
CONTRAINDICATIONS: Gentamicin Sulfate Ophthalmic Solution is contraindicated in patients with known hypersensitivity to any of the components.
WARNINGS SECTION
WARNINGS: NOT FOR INJECTION INTO THE EYE. Gentamicin Sulfate Ophthalmic Solution is not for injection. It should never be injected subconjunctivally, nor should it be directly introduced into the anterior chamber of the eye.
PRECAUTIONS SECTION
PRECAUTIONS: General: Prolonged use of topical antibiotics may give rise to overgrowth of non-susceptible organisms including fungi. Bacterial resistance to gentamicin may also develop. If purulent discharge, inflammation or pain becomes aggravated, the patient should discontinue use of the medication and consult a physician. If irritation or hypersensitivity to any component of the drug develops, the patient should discontinue use of this preparation, and appropriate therapy should be instituted.
INFORMATION FOR PATIENTS SECTION
Information for Patients: To avoid contamination, do not touch tip of container to the eye, eyelid, or any surface.
CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY SECTION
Carcinogenesis, Mutagenesis, Impairment of Fertility: There are no published carcinogenicity or impairment of fertility studies on gentamicin. Aminoglycoside antibiotics have been found to be non-mutagenic.
PREGNANCY SECTION
Pregnancy: Pregnancy Category C. Gentamicin has been shown to depress body weights, kidney weights, and median glomerular counts in newborn rats when administered systemically to pregnant rats in daily doses approximately 500 times the maximum recommended ophthalmic human dose. There are no adequate and well-controlled studies in pregnant women. Gentamicin should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.
PEDIATRIC USE SECTION
Pediatric Use: Safety and effectiveness in neonates have not been established.
ADVERSE REACTIONS SECTION
ADVERSE REACTIONS: Bacterial and fungal corneal ulcers have developed during treatment with gentamicin ophthalmic preparations. The most frequently reported adverse reactions are ocular burning and irritation upon drug instillation, non-specific conjunctivitis, conjunctival epithelial defects, and conjunctival hyperemia. Other adverse reactions which have occurred rarely are allergic reactions, thrombocytopenic purpura, and hallucinations.
DOSAGE & ADMINISTRATION SECTION
DOSAGE AND ADMINISTRATION: Instill one or two drops into the affected eye(s) every four hours. In severe infections, dosage may be increased to as much as two drops once every hour.
HOW SUPPLIED SECTION
HOW SUPPLIED: Gentamicin Sulfate Ophthalmic Solution: 5 mL in plastic DROP-TAINER* dispenser. NDC 71205-333-05
STORAGE: Protect from light and store away from heat. Store at controlled room temperature 15°-25°C (59°-77°F).
To report SUSPECTED ADVERSE REACTIONS, contact Sandoz Inc., at 1-800-525-8747 or FDA at 1-800-FDA-1088 or
www.fda.gov/medwatch.
*DROP-TAINER is a registered trademark of Alcon Research, Ltd.
Rx Only
SPL UNCLASSIFIED SECTION
9011648-0315
Manufactured by
Alcon Laboratories, Inc.
Fort Worth, Texas 76134 for
Sandoz Inc.
Princeton, NJ 08540
Relabeled by
Proficient Rx LP
Thousand Oaks, CA 91320
Rev. April 2015
PRINCIPAL DISPLAY PANEL
DailyMed RxNorm Mappings#
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| GENTAMICIN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 3b7b3a7a-635f-32a3-0c6c-7ad028e3de91 | Product name | 2 | 20250107 |
| 43025f0d-698c-68da-cec9-ea4261a7ef7a | Product name | 2 | 20250107 |
| d3946667-8212-d1f2-67e1-5643a329bb56 | Product name | 2 | 20200403 |
| 4ce5dce5-e8a7-e4f6-0059-b527e4307477 | Product name | 2 | 20190501 |
| 48b05f5d-d2fc-45ab-76e8-3cb5bd44890d | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71205-333-05 | Gentamicin Sulfate | 5 mL in 1 BOTTLE, PLASTIC | SOLUTION | 5 | 3 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 71205-333-05 | ML - Milliliter | 71205-333 | 2def3409-36d2-414b-bd2f-0229bb18382d | 1 | 2019-11-12 |
| 61314-633-05 | ML - Milliliter | 61314-633 | 7f3d9c77-40cf-4ab8-9b40-b966eba61047 | 1 | 2012-07-24 |
Products#
Every source-derived product name is available through these pages.
- Gentamicin Sulfate
- GENTAMICIN
- BENZALKONIUM CHLORIDE
- SODIUM CHLORIDE
- SODIUM PHOSPHATE
- TYLOXAPOL
- SODIUM HYDROXIDE
- HYDROCHLORIC ACID
- WATER
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 71205-333 | 71205-333-05 |
| 61314-633 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| GENTAMICIN SULFATE | 8X7386QRLV | ACTIM |
| BENZALKONIUM CHLORIDE | F5UM2KM3W7 | IACT |
| SODIUM CHLORIDE | 451W47IQ8X | IACT |
| SODIUM PHOSPHATE | SE337SVY37 | IACT |
| TYLOXAPOL | Y27PUL9H56 | IACT |
| SODIUM HYDROXIDE | 55X04QC32I | IACT |
| HYDROCHLORIC ACID | QTT17582CB | IACT |
| WATER | 059QF0KO0R | IACT |
Source Document#
Orange Book application contexts#
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A062196-001 | GENTAMICIN SULFATE | GENTAMICIN SULFATE | EQ 0.3% BASE | SOLUTION/DROPS / OPHTHALMIC | AT | RS, Approved before 1982 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A062196-001 | AT |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | A062196-001 | GENTAMICIN SULFATE | EQ 0.3% BASE | SOLUTION/DROPS / OPHTHALMIC | AT | RS, Approved before 1982 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | A062196-001 | GENTAMICIN SULFATE | EQ 0.3% BASE | SOLUTION/DROPS / OPHTHALMIC | AT | RS, Approved before 1982 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A062196-001 | GENTAMICIN SULFATE | EQ 0.3% BASE | SOLUTION/DROPS / OPHTHALMIC | AT | RS, Approved before 1982 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A062196-001 | GENTAMICIN SULFATE | EQ 0.3% BASE | SOLUTION/DROPS / OPHTHALMIC | AT | RS, Approved before 1982 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A062196-001 | GENTAMICIN SULFATE | EQ 0.3% BASE | SOLUTION/DROPS / OPHTHALMIC | AT | RS, Approved before 1982 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A062196-001 | GENTAMICIN SULFATE | EQ 0.3% BASE | SOLUTION/DROPS / OPHTHALMIC | AT | RS, Approved before 1982 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A062196-001 | GENTAMICIN SULFATE | EQ 0.3% BASE | SOLUTION/DROPS / OPHTHALMIC | AT | RS, Approved before 1982 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A062196-001 | GENTAMICIN SULFATE | EQ 0.3% BASE | SOLUTION/DROPS / OPHTHALMIC | AT | RS, Approved before 1982 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A062196-001 | GENTAMICIN SULFATE | EQ 0.3% BASE | SOLUTION/DROPS / OPHTHALMIC | AT | RS, Approved before 1982 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A062196-001 | GENTAMICIN SULFATE | EQ 0.3% BASE | SOLUTION/DROPS / OPHTHALMIC | AT | RS, Approved before 1982 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A062196-001 | GENTAMICIN SULFATE | EQ 0.3% BASE | SOLUTION/DROPS / OPHTHALMIC | AT | RS, Approved before 1982 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A062196-001 | GENTAMICIN SULFATE | EQ 0.3% BASE | SOLUTION/DROPS / OPHTHALMIC | AT | RS, Approved before 1982 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A062196-001 | GENTAMICIN SULFATE | EQ 0.3% BASE | SOLUTION/DROPS / OPHTHALMIC | AT | RS, Approved before 1982 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A062196-001 | GENTAMICIN SULFATE | EQ 0.3% BASE | SOLUTION/DROPS / OPHTHALMIC | AT | RS, Approved before 1982 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A062196-001 | GENTAMICIN SULFATE | EQ 0.3% BASE | SOLUTION/DROPS / OPHTHALMIC | AT | RS, Approved before 1982 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A062196-001 | GENTAMICIN SULFATE | EQ 0.3% BASE | SOLUTION/DROPS / OPHTHALMIC | AT | RS, Approved before 1982 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A062196-001 | GENTAMICIN SULFATE | EQ 0.3% BASE | SOLUTION/DROPS / OPHTHALMIC | AT | RS, Approved before 1982 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A062196-001 | GENTAMICIN SULFATE | EQ 0.3% BASE | SOLUTION/DROPS / OPHTHALMIC | AT | Approved before 1982 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A062196-001 | GENTAMICIN SULFATE | EQ 0.3% BASE | SOLUTION/DROPS / OPHTHALMIC | AT | Approved before 1982 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A062196-001 | GENTAMICIN SULFATE | EQ 0.3% BASE | SOLUTION/DROPS / OPHTHALMIC | AT | Approved before 1982 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | A062196-001 | GENTAMICIN SULFATE | EQ 0.3% BASE | SOLUTION/DROPS / OPHTHALMIC | AT | Approved before 1982 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | A062196-001 | GENTAMICIN SULFATE | EQ 0.3% BASE | SOLUTION/DROPS / OPHTHALMIC | AT | Approved before 1982 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | A062196-001 | GENTAMICIN SULFATE | EQ 0.3% BASE | SOLUTION/DROPS / OPHTHALMIC | AT | Approved before 1982 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A062196-001 | GENTAMICIN SULFATE | EQ 0.3% BASE | SOLUTION/DROPS / OPHTHALMIC | AT | Approved before 1982 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | A062196-001 | GENTAMICIN SULFATE | EQ 0.3% BASE | SOLUTION/DROPS / OPHTHALMIC | AT | Approved before 1982 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | A062196-001 | GENTAMICIN SULFATE | EQ 0.3% BASE | SOLUTION/DROPS / OPHTHALMIC | AT | Approved before 1982 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | A062196-001 | GENTAMICIN SULFATE | EQ 0.3% BASE | SOLUTION/DROPS / OPHTHALMIC | AT | Approved before 1982 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | A062196-001 | GENTAMICIN SULFATE | EQ 0.3% BASE | SOLUTION/DROPS / OPHTHALMIC | AT | Approved before 1982 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | A062196-001 | GENTAMICIN SULFATE | EQ 0.3% BASE | SOLUTION/DROPS / OPHTHALMIC | AT | Approved before 1982 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | A062196-001 | GENTAMICIN SULFATE | EQ 0.3% BASE | SOLUTION/DROPS / OPHTHALMIC | AT | Approved before 1982 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A062196-001 | GENTAMICIN SULFATE | EQ 0.3% BASE | SOLUTION/DROPS / OPHTHALMIC | AT | RS, Approved before 1982 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | A062196-001 | GENTAMICIN SULFATE | EQ 0.3% BASE | SOLUTION/DROPS / OPHTHALMIC | AT | RS, Approved before 1982 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | A062196-001 | GENTAMICIN SULFATE | EQ 0.3% BASE | SOLUTION/DROPS / OPHTHALMIC | AT | RS, Approved before 1982 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A062196-001 | GENTAMICIN SULFATE | EQ 0.3% BASE | SOLUTION/DROPS / OPHTHALMIC | AT | RS, Approved before 1982 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A062196-001 | GENTAMICIN SULFATE | EQ 0.3% BASE | SOLUTION/DROPS / OPHTHALMIC | AT | RS, Approved before 1982 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A062196-001 | GENTAMICIN SULFATE | EQ 0.3% BASE | SOLUTION/DROPS / OPHTHALMIC | AT | RS, Approved before 1982 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A062196-001 | GENTAMICIN SULFATE | EQ 0.3% BASE | SOLUTION/DROPS / OPHTHALMIC | AT | RS, Approved before 1982 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | A062196-001 | GENTAMICIN SULFATE | EQ 0.3% BASE | SOLUTION/DROPS / OPHTHALMIC | AT | RS, Approved before 1982 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | A062196-001 | GENTAMICIN SULFATE | EQ 0.3% BASE | SOLUTION/DROPS / OPHTHALMIC | AT | Approved before 1982 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A062196-001 | GENTAMICIN SULFATE | EQ 0.3% BASE | SOLUTION/DROPS / OPHTHALMIC | AT | Approved before 1982 | 3a93d1ddd44b… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | A062196-001 | AT | 1 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | A062196-001 | AT | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A062196-001 | AT | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A062196-001 | AT | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A062196-001 | AT | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A062196-001 | AT | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A062196-001 | AT | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A062196-001 | AT | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A062196-001 | AT | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A062196-001 | AT | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A062196-001 | AT | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A062196-001 | AT | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A062196-001 | AT | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A062196-001 | AT | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A062196-001 | AT | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A062196-001 | AT | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A062196-001 | AT | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A062196-001 | AT | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A062196-001 | AT | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A062196-001 | AT | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A062196-001 | AT | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A062196-001 | AT | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A062196-001 | AT | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A062196-001 | AT | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A062196-001 | AT | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | A062196-001 | AT | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A062196-001 | AT | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | A062196-001 | AT | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A062196-001 | AT | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A062196-001 | AT | 1 | ea99ee380514… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A062196-001 | AT | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | A062196-001 | AT | 1 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | A062196-001 | AT | 1 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A062196-001 | AT | 1 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A062196-001 | AT | 1 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A062196-001 | AT | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A062196-001 | AT | 1 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | A062196-001 | AT | 1 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | A062196-001 | AT | 1 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A062196-001 | AT | 1 | 3a93d1ddd44b… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gentamicin Sulfate | GENTAMICIN SULFATE | Proficient Rx LP | 5193ed8d-44c9-46fe-924d-93aaea922cfd | 2025-05-01 | Warnings, Adverse reactions | 71205-333-05 71205-333 71205033305 f7b2d19f-57fe-4aae-a6be-c9f4525e1438 5193ed8d-44c9-46fe-924d-93aaea922cfd |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Sandoz Inc | a213fb9c-08ea-4f30-a6c9-93c7a9ba5280 | 2024-01-02 | Warnings, Adverse reactions | 61314-633 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
